eFFECTOR Therapeutics
USEntry
2013
Hold
8yr
Exit
2021
Who owns eFFECTOR Therapeutics?
eFFECTOR Therapeutics was owned by Abingworth through Abingworth Bioventures VI (2014 vintage) from 2013 to 2021, exited via IPO.
Buyer identity available on Pro.
Hand-verified · updated 2026-05-21
Exit Type
IPO
Buyer
MOIC
–
Exit Year
2021
More from Abingworth Bioventures VI
Other portfolio companies in the same fund.
UK
FranceMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Track eFFECTOR Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy eFFECTOR Therapeutics?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on eFFECTOR Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue